Produção Nacional
Revisado por pares
Morita–Baylis–Hillman adducts: Biological activities and potentialities to the discovery of new cheaper drugs
2012; Elsevier BV; Volume: 20; Issue: 13 Linguagem: Inglês
10.1016/j.bmc.2012.04.061
ISSN1464-3391
AutoresCláudio Gabriel Lima-Júnior, Mário L. A. A. Vasconcellos,
Tópico(s)Synthesis of heterocyclic compounds
ResumoThis review aims to present by the first time the Morita–Baylis–Hillman adducts (MBHA) as a new class of bioactive compounds and highlight its potentialities to the discovery of new cheaper and efficient drugs. Now, most these compounds can be prepared fast and on a single synthetic step (one-pot reaction) in high yields and using ecofriendly synthetic protocols. We highlight here the aromatic MBHA, which have shown diverse biological activities as anti-Leishmania chagasi and Leishmania amazonensis (parasites that cause cutaneous and visceral leishmaniasis), anti-Trypanosoma cruzi (parasite that cause Chagas disease), anti-Plasmodium falciparum and Plasmodium berghei (parasites that cause malaria), lethal against Biomphalaria glabrata (the snail transmitter of schistosomiasis), antibacterial, antifungal, herbicide and actives against some human tumor cell lines. Understanding of the biological mechanisms of action of this new class of molecules is still in the infancy stage. However, we report here which has been described to date on the possibilities of biological mechanisms of action, and we present new analyzes based on literature in this area. The academic and industrial interest in selecting green and cheaper experiments to the drugs development has been the prime mover of the growth on the subject.
Referência(s)